Correction: Vertex Hepatis C Drug
By APWednesday, January 13, 2010
Correction: Vertex Hepatis C Drug
CAMBRIDGE, Mass. — In a story Jan. 11 about Vertex Pharmaceuticals Inc. and its hepatitis C drug, The Associated Press misstated when the company will seek regulatory approval for the drug. Approval will be requested in the second half of 2010, not 2009.
Tags: Cambridge, Diagnosis And Treatment, Diseases And Conditions, Infectious Diseases, Liver Disease, Massachusetts, Medication, North America, United States
|
April 20, 2010: 12:13 pm
Thanks for your posting. You have a lot of good, important information regarding hep-C and treatments. Treatments for hepatitis C are one of the research studies we’ve been working on here in DeLand, Florida. Some of our investigational treatments have shown promising results, but there is a need to do additional research studies to test investigational methods that may help us understand the condition. If you could pass on the word to your readership it would be incredibly helpful to those suffering from hep-C. |
Don